Hong Kong stock innovative medicine ETF trading volume exceeds 7.5 billion yuan, currently up 0.75%.

The turnover of the Hong Kong stock innovation drug ETF exceeded 7.5 billion yuan, with a current increase of 0.75%. The turnover was 75.39 billion yuan, with a net inflow of financing of 485 million yuan on the 3rd. In the past month, the shares decreased by 458 million. The fund supports T+0 trading.